Related Experiment Video
Updated: Dec 23, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Conducting clinical trials during the COVID-19 pandemic
Erin K Collier1, Jennifer L Hsiao2, Vivian Y Shi3
1David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Abstract:
The COVID-19 pandemic has greatly impacted dermatology clinical trial operations due to mandated governmental and institutional shut-downs and newly implemented restrictions. During this unprecedented time, measures should be taken to maintain research conduct compliance while also ensuring the safety of trial staff and participants. Herein, we underscore the challenges facing dermatology trials during the COVID-19 pandemic, and offer strategies to maintain compliant and safe conduct.
Insights
The COVID-19 pandemic disrupted dermatology clinical trials. This study offers strategies to ensure compliant and safe research conduct during the public health crisis.
Area of Science:
- Dermatology
- Clinical Research
- Public Health
Background:
- The COVID-19 pandemic significantly disrupted dermatology clinical trial operations.
- Governmental and institutional shutdowns, along with new restrictions, created unprecedented challenges for ongoing research.
Purpose of the Study:
- To identify the challenges faced by dermatology clinical trials during the COVID-19 pandemic.
- To propose strategies for maintaining compliant and safe research conduct amidst the pandemic.
Main Methods:
- Review of operational impacts of the COVID-19 pandemic on dermatology clinical trials.
- Identification of key challenges in maintaining research integrity and participant safety.
- Development of actionable strategies for compliant and safe trial conduct.
Main Results:
- Dermatology trials faced significant operational hurdles due to pandemic-related restrictions.
- Maintaining research compliance and ensuring the safety of staff and participants were primary concerns.
- Specific strategies are needed to navigate these challenges effectively.
Conclusions:
- The COVID-19 pandemic necessitated adaptive strategies in dermatology clinical trials.
- Implementing robust safety protocols and flexible operational plans is crucial.
- Ensuring continued, compliant research is vital for advancing dermatological science.
More Related Videos
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Bioavailability Study Design: Healthy Subjects Versus Patients
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

